102
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Bioengineered Solutions to Improve Cancer Immunotherapies

ORCID Icon & ORCID Icon
Pages 339-341 | Received 02 Feb 2021, Accepted 05 Mar 2021, Published online: 17 Mar 2021
 

Author contributions

OA Mandrup and KA Howard wrote the manuscript. All authors have read and approved the final manuscript.

Financial & competing interests disclosure

The authors would like to acknowledge CEMBID (Center for Multifunctional Biomolecular Drug Design, Grant Number: NNF17OC0028070) for funding to OA Mandrup and KA Howard. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 351.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.